THIS ANNOUNCEMENT AND THE
INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR
DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR
INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH
AFRICA, JAPAN OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO
DO SO
THIS ANNOUNCEMENT IS AN ADVERTISEMENT
FOR THE PURPOSES OF THE UK PROSPECTUS REGULATION RULES OF THE
FINANCIAL CONDUCT AUTHORITY (THE "FCA") AND DOES NOT CONSTITUTE A
PROSPECTUS OR A PROSPECTUS EQUIVALENT DOCUMENT.
LEI: 2549008KZ7HM27V4O637
Marwyn Acquisition Company II
Limited
(the
"Company")
Publication of the Financial
Statements for the year ended 30 June 2024
The Company announces the
publication of its Annual Report and Financial Statements for the
year ended 30 June 2024.
The Financial Statements are also
available on the 'Shareholder Documents' page of the Company's
website at www.marwynac2.com.
Publication of Supplementary Prospectus
The publication of the Company's
Annual Report and Financial Statements requires the Company to
publish a supplementary prospectus (the "Supplementary Prospectus") to its
prospectus dated 1 July 2024 (the "Original Prospectus"). The Company will
make a separate announcement following the FCA's approval of the
Supplementary Prospectus.
Acquisition of InvestAcc
The Acquisition is conditional upon,
amongst other things, the FCA having given written notice to MAC II
UK that the FCA approves the acquisition of control by MAC II UK
over the companies within the InvestAcc Group that are FCA
authorised. Completion is anticipated to take place in Q3 / early
Q4 2024.
Following Completion, the Company
will become a trading entity and will provide further financial
information on the trading outlook for the Enlarged
Group.
Defined terms used in this
announcement shall have the meaning given in the Original
Prospectus, unless otherwise defined.
IMPORTANT INFORMATION:
This announcement has been prepared
by, and is the sole responsibility of, the Directors of Marwyn
Acquisition Company II Limited.
This announcement is an
advertisement and does not constitute a prospectus relating to the
Company and does not constitute, or form part of, any offer or
invitation to sell or issue, or any solicitation of any offer to
subscribe for, any shares in the Company in any jurisdiction nor
shall it, or any part of it, or the fact of its distribution, form
the basis of, or be relied on in connection with or act as any
inducement to enter into, any contract therefor. The Original
Prospectus is, and when published the Supplementary Prospectus will
be, available from the Company's website
at www.marwynac2.com/investors/shareholder-documents.
Neither the content of the Company's
website, nor the content on any website accessible from hyperlinks
on its website for any other website, is incorporated into, or
forms part of, this announcement nor, unless previously published
by means of a recognised information service, should any such
content be relied upon in reaching a decision as to whether or not
to acquire, continue to hold, or dispose of, securities in the
Company.
Enquiries:
Company Secretary
Antoinette Vanderpuije - 020 7004
2700
Zeus Capital Limited - Corporate Broker
- +44 (0) 207 220
1666
Harry Ansell
Katy Mitchell
MARWYN ACQUISITION COMPANY II
LIMITED
Annual
Report and Audited Consolidated Financial Statements
For the
year ended 30 June 2024
MANAGEMENT REPORT
We present to shareholders the
audited consolidated financial statements of Marwyn Acquisition
Company II Limited (the "Company") for the year ended 30 June
2024 (the "Financial
Statements"), consolidating the results of Marwyn
Acquisition Company II Limited and its subsidiaries; MAC II (BVI)
Limited, and MAC II UK Limited (collectively, the "Group" or "MAC").
Acquisition of InvestAcc
On 28 June 2024, the Company
announced that its subsidiary, MAC II UK Limited, had entered into
binding agreements to acquire 100 per cent. of the issued share
capital of InvestAcc Group Limited ("InvestAcc"), a leading pensions
services provider, for £41.5 million, representing an enterprise
value of approximately £36 million on a cash-free debt-free basis
(the "Acquisition"), partly
funded via a £30 million institutional placing and subscription
(effective 4th July 2024) and the issue of 6,150,911
consideration shares ("Consideration Shares"). The
Acquisition is subject to the approval of the Financial Conduct
Authority ("FCA"), on
receipt of which the Acquisition will complete ("Completion"). On Completion, the
Company intends to change its name to InvestAcc Group
Limited.
InvestAcc was founded in 1992 by CEO
Nick Gardner as DHC Brokers Ltd. Initially it serviced the
financial planning requirements of one of Cumbria's accountancy
practises. The business is now a leading UK personal pension
administrator, having a proven track record of delivering
exceptional customer service, scalable operations and
infrastructure, a strong financial profile and a sustainable
organic growth trajectory. All of the management team, including
the founder, are expected to stay with the business post
completion. InvestAcc has two principal subsidiaries, InvestAcc
Pension Administration Limited ("IPA") and Vesta Wealth Limited
("Vesta").
IPA offers Self Invested Personal
Pension ("SIPP") and Small
Self Administered Scheme ("SSAS") products distributed primarily
through Independent Financial Advisers ("IFAs") throughout the UK, with over
1,000 supporting advisers. With the exception of UK fixed term
deposit accounts, IPA does not accept any new non-standard assets
into any of its schemes. IPA's flagship plan is the "Minerva SIPP",
which is a full SIPP allowing investment in any permitted standard
asset. The "SIPP Lite" scheme is a lower cost, simpler SIPP and
allows investment in a single investment, such as a discretionary
fund manager portfolio plus a bank account. Vesta is a
chartered financial planner that offers holistic advice to a wide
range of customers. It provides initial and ongoing advice under
service agreements with over £450 million of Assets Under
Administration ("AuA").
Strategic Rationale and market opportunity
MAC's strategy is to build the UK's
leading specialist pensions administration business in the public
markets with an initial focus on the SIPP segment, a highly
attractive investment opportunity. InvestAcc is the first and key
step in executing this strategy.
1.
InvestAcc is a highly scalable
platform business: an award-winning provider of SIPP
and SSAS services in the UK with a strong commitment to high
quality customer service and outcomes. This is evidenced by their
customer service score of 96 per cent., winning best pension
service provider four years running between 2020 and 2023, and
winning the best SIPP provider in 2023. The business provides the
optimal strategic platform to create value, possessing scalable
operations and infrastructure, a strong financial profile -
generating £8.8 million of revenue and £3.6 million of adjusted
Earnings before interest tax depreciation and amortisation
("EBITDA") for FY23 - and a
sustainable organic growth trajectory. The Acquisition represents a
unique opportunity to develop the UK's leading specialist pensions
administration business with an initial focus on the SIPP
Segment.
2.
Long term structural market
growth: favourable macroeconomic trends and the evolution of
the pension industry have created a drive towards personal pensions
(including SIPPs). Total SIPP market AuA are expected to grow
at an 8% Compound Annual Growth Rate ("CAGR") over the next 5-years from
c.£500 billion to c.£750 billion.
3.
Excellent underlying business
fundamentals: Full SIPP administrators typically have a
customer retention rate of above 90 per cent., creating an ongoing
fee-based revenue stream. The average SIPP plan lasts for more than
25 years, benefitting from embedded growth through contractual
inflation-linked fees. Industry average EBITDA margins exceed 30
per cent. with strong cashflow conversion.
4.
Near term M&A consolidation
opportunity with a robust pipeline: there is a highly
attractive mergers and acquisitions ("M&A") landscape for acquiring Full
SIPP and Simple SIPP administrators across a range of sellers.
Regulatory pressure, underpinned by a push for higher levels of
consumer duty care, as well as vendor needs, are driving the sector
to consolidate actively. MAC has a robust pipeline primarily
sourced directly by the management team who are in active
discussions in relation to five potential acquisitions with vendors
which combined could deliver more than £20 billion of AuA and
45,000 customers in 2024 and 2025.
5.
A sector leading team with M&A
track record: the Company's management team have over 65
years of combined operational and strategic experience in the
financial services and wealth sector, and have led multiple
successful transactions. The MAC management team are supported by
Marwyn's M&A and capital markets expertise, who have a track
record of successful public market fund raises, having raised over
£3.9 billion to date across 12 comparable vehicles delivering £4.9
billion in gross equity profits for investors.
Results
The Group's total comprehensive loss
for the year to 30 June 2024 was £2,971,103 (2023: £3,527,899). Of
the costs incurred in the year, £115,500 (2023:
£2,017,600) relates
to non-recurring project costs and £1,717,914 (2023: £nil) of acquisition related costs as
disclosed in Note 6 of these Financial
Statements. The Group held a cash balance at the year end of £6,461,475 (2023:
£7,783,448).
During the year reported in these
Financial Statements, the Group had not acquired an operating
business and as such only generated interest income on its bank
deposits.
Historic financial information on
InvestAcc is included in the prospectus issued in respect of the
Acquisition dated 1 July 2024 (the "Prospectus"), and its results will be
consolidated by the Company from Completion.
Dividend Policy
The Company has not yet adopted a
dividend policy, however, as set out in the Prospectus, the
Directors recognise the importance of dividends to investors, both
as a key component of shareholder value creation and as a
discipline on the business of the Company. The board of Directors
(the "Board") will
determine the appropriate dividend policy following Completion, but
it expects to adopt a progressive dividend policy.
The Company has stated, that subject
to Completion, the Company will announce its dividend policy at the
same time as it publishes its interim results for the interim
financial period to 31 December 2024. The Board intends that such
policy will stipulate that, for financial years of the Company
following the adoption of such policy, any interim dividends paid
by the Company will be equal to one third of the total dividend
(interim plus final) paid by the Company in the prior financial
year.
Key
Performance Indicators
As at the date of this report, the
Company has not yet acquired a trading business and therefore no
key performance indicators have been set. Following
Completion, the Directors will formally adopt key performance
indicators for the consolidated performance of MAC and InvestAcc
(the "Enlarged
Group").
Stated Capital and significant shareholdings
Details of the stated capital of the
Company during the year are set out in Note 15. At the balance
sheet date, the Company had in issue 700,000 Ordinary Shares and
matching warrants, 12,000,000 A Shares and matching warrants and 1
Sponsor Share.
As disclosed in Note 22, on 4 July
2024 the placing and subscription in relation to the Acquisition
were completed which resulted in the following changes to stated
capital and warrants;
· the
Company issued 30,000,000 New Ordinary Shares of no par value for
£30 million in cash in order to fund the Acquisition;
· the
12,000,000 A Shares managed by Marwyn Investment Management LLP
("MIM LLP") on behalf of
funds under discretionary management were converted into New
Ordinary Shares; and
· the
12,000,000 A Warrants held by MIM LLP on behalf of funds under
discretionary management were surrendered and cancelled.
Following these transactions, as at
the date of this report, the Company has in issue 42,700,000
Ordinary Shares of no par value and 700,000 ordinary
warrants.
On Completion of the acquisition,
the 6,150,911 Consideration Shares will be issued. The
Consideration Shares will be subject to a 12 month Lock-in Period,
with a requirement that any sale of Consideration Shares in the 12
months following the end of the Lock-in Period (the "Restricted Period") may only be made on
the basis that an orderly market in the Ordinary Shares is
maintained.
The table below shows significant
shareholders at the balance sheet date, at the date of this report
and, based on the significant shareholders at the date of this
report, the expected interests held following the issuance of the
Consideration Shares.
Significant shareholder
|
Interest at the Balance Sheet date
|
Interest at the date of this report
|
Expected interest following issuance of Consideration
Shares
|
Marwyn Investment Management
LLP
|
75.0%
|
68.4%
|
59.8%
|
Nicholas Gardner
|
-
|
-
|
12.7%
|
M&G Investment Management
(Recovery)
|
-
|
4.7%
|
4.1%
|
M&G Investment Management (Small
Cap)
|
-
|
4.7%
|
4.1%
|
River Global Investors
LLP
|
-
|
4.6%
|
4.0%
|
Dowgate Wealth Management
|
-
|
3.9%
|
3.4%
|
Killik & Co. LLP
|
-
|
3.5%
|
3.1%
|
Octopus Investments
|
-
|
3.0%
|
2.7%
|
Avril Palmer-Baunack
|
4.9%
|
1.3%
|
1.1%
|
Tim Lampert
|
4.9%
|
0.3%
|
0.3%
|
Simon Vivian
|
4.9%
|
0.3%
|
0.3%
|
Darren Throop
|
4.9%
|
0.1%
|
0.1%
|
Corporate Governance
The Board is committed to
maintaining high standards of corporate governance. At the date of
this report, the Company has not yet completed its platform
acquisition, and therefore given the size and nature of the Group,
the Directors have decided not to adopt the UK Corporate Governance
Code nor to establish committees until Completion.
During the year and subsequently,
the Company complied with the following principles of the UK
Corporate Governance Code:
· The
Company is led by an effective and entrepreneurial Board, whose
role is to promote the long term sustainable success of the
Company, generating value for shareholders and contributing to
wider society;
· The
Board ensures that it has the policies, processes, information,
time and resources it needs in order to function effectively and
efficiently; and
· The
Board ensures that the necessary resources are in place for the
Company to meet its objectives and measure performance against
them.
The Company had always committed to
revisiting its compliance with the UK Corporate Governance Code at
around the time of a platform acquisition. As set out in the
Prospectus, the Company has committed to adopt the UK Corporate
Governance Code on Completion, establishing Audit, Risk, Nomination
and Remuneration Committees and to appoint at least three
non-executive directors on or around Completion.
Directors
The Directors of the Company who
served during the year and to the date of this report
are:
Mark Hodges (Chair);
Will Self (Chief Executive
Officer);
James Pearce (Chief Financial
Officer) (appointed 23 May 2024)
James Corsellis (Non-Executive
Director); and
Cathryn Riley (Non-Executive
Director) (resigned 23 May 2024).
Directors' Biographies
Mark Hodges has over 30 years'
experience across the financial services and consumer sectors,
including extensive FTSE 100 board experience with Centrica plc and
Aviva plc. He was also CEO of ReAssure (which he sold to Phoenix
for £3.25 billion), Centrica's consumer division (including British
Gas), Towergate Insurance, and Aviva UK. Mark is currently the
independent non-executive chairman of the Royal Sun Alliance
Insurance Group, a wholly owned subsidiary of the Intact Finance
Corporation.
Will Self has extensive
experience across pension and retirement services sectors. He was
previously Chief Executive Officer of Suffolk Life and Chief
Commercial Officer of Cofunds (both divisions of Legal &
General), and subsequently CEO of Curtis Banks Group plc. During
his time at Suffolk Life, Will led one of the SIPP industry's first
consolidation initiatives including the acquisition of the full
SIPP book from Pointon York in 2012, the merger with Curtis Banks
in 2016, and the acquisition of Talbut and Muir. Will is also a
Trustee of the Seckford Foundation and serves as Deputy Chair to
the FCA Small Business Practitioner Panel. He holds an MBA from
Cranfield School of Management.
James Pearce has experience in
the pensions and insurance industry, and in capital markets. He was
previously CFO of the Pension SuperFund and Director of Group
Finance at Just Group plc. He is a Chartered Accountant and held
managing director roles at JP Morgan Cazenove and UBS.
James Corsellis is Managing
Partner of Marwyn Capital and Chief Investment Officer of MIMLLP He
brings extensive public company experience, management and
corporate finance expertise across a range of sectors, and an
extensive network of relationships with coinvestors, advisers and
other business leaders. He is chairman of Marwyn Acquisition
Company III Limited and MAC Alpha Limited, and a director of 450
plc and Silvercloud Holdings Limited. Previously he has served as
Chairman of Entertainment One, CEO of icollector plc; and as a
non-executive director of BCA Marketplace, Advanced Computer
Software and Breedon Aggregates.
Risk management and internal control systems
During the financial year, prior to
work commencing on the Acquisition, the Company had in place a
robust risk framework which identified and assessed the risks faced
by the business whilst it was a cash shell. The Company's risk
management framework incorporated a risk assessment that identified
and assessed the strategic, operational and financial risks facing
the business and their mitigating controls. The risk assessment was
documented through a risk register which categorised the key risks
faced by the business into:
•
Business risks;
•
Shareholder risks;
•
Financial and procedural risks; and
•
Risks associated with an acquisition.
As part of the Acquisition, the
Directors, with the support of their advisers, considered and
documented the ongoing risk management framework for the Enlarged
Group, both identifying the key risks facing the Company during
this interim period whilst the Company is seeking change in control
approval from the FCA, and subsequently following Completion where
the Company will have operational control of InvestAcc.
The Prospectus identifies and
describes a wide range of risks facing the business as at the date
of this report, and also those relating to the Enlarged Group
(including the Company, its subsidiaries and the InvestAcc Group)
following Completion. The prospectus is available to view at
www.marwynac2.com/investors.
The risk assessment performed as
part of the Acquisition identifies the potential impact and
likelihood of each of the risks detailed on the risk register and
mitigating factors/actions have also been identified along with key
risk indicators that will enable the Company's management to
monitor the risks posed. The risk matrix groups risks into
strategic risks, operational risks, shareholder risks and risks
which impact the financial position and prospects.
The Company's risk management
process includes both formal and informal elements. The size of the
Board and the frequency in which they interact ensures that risks,
or changes to the nature of the Company's existing risks, are
identified, discussed and analysed quickly. The Company's
governance framework, including formal periodic board meetings with
standing agendas, ensures that the Company has a formal framework
in place to manage the review, consideration and formal approval of
the risk register, including risk assessment.
At the date of this report, the
Board of Directors is responsible for the risk management framework
of the Group, and on at least an annual basis the Enlarged Group's
risk matrix is tabled for review and consideration. Effective on
Completion, the Company will establish a Risk Committee who will be
delegated responsibility for the risk management of the Enlarged
Group. The Risk Committee will comprise of a minimum of two
independent non-executive directors who are expected to be
appointed on, or shortly after, Completion.
The Directors have set out below the
principal risks faced by the business at the date of this report.
These are the risks the Directors consider to be most relevant to
the Company based on its current status. The risks referred to
below do not purport to be exhaustive and are not set out in any
particular order of priority.
Key
risk
|
Explanation
|
Successful completion &
integration of InvestAcc Limited
|
It is possible that the Group may
not obtain the relevant regulatory clearances (including but not
limited to the approval or authorisation of the Acquisition from
the FCA), or that they may not be obtainable prior to the
Acquisition Long Stop Date, or that they may only be obtained
subject to certain conditions or undertakings, such as the disposal
of parts of the Avanti Group business, which may not be acceptable
to the Group.
|
Follow-on acquisitions
|
The Company intends to make further
acquisitions of companies or books of business which may divert
management attention away from the successful integration of the
Enlarged Group.
In addition, further acquisitions
may involve risks of undisclosed liabilities and integration issues
that are not revealed in the due diligence process. It could
also result in the incurrence of additional indebtedness, costs,
contingent liabilities, and impairment and amortisation expenses
related to goodwill and other intangible assets. The success
of future follow-on acquisitions will also rely on their successful
integration to the Enlarged Group.
|
The Company may be unable to obtain
additional funding needed to implement its
strategy.
|
There may be significant competition
for some or all of the acquisition opportunities that the Company
may explore. The Company intends to seek additional sources of
financing (equity and/or debt) to implement its strategy. There can
be no assurance that the Company will be able to raise those funds,
whether on acceptable terms or at all which may prevent the desired
growth plans for the Enlarged Group from being achieved and may
have a negative impact on the Company's reputation.
|
The Company could incur costs for
transactions that may ultimately be unsuccessful
|
There is a risk that the Company may
incur substantial legal, financial and advisory expenses arising
from unsuccessful transactions which may include public offer and
transaction documentation, legal, accounting and other due
diligence.
|
Regulatory change
|
The Enlarged Group will operate in
an industry which is subject to the regular introduction of new
laws and regulation as well as retrospective changes to existing
laws. Changes in government policy, legislation or regulatory
interpretation applying to companies in the financial services
industry in the UK, which may be applied retrospectively, may
adversely affect the Enlarged Group's product range, distribution
channels, capital requirements and, consequently, results and
financing requirements.
|
Directors' interests
At the balance sheet date, the
Directors had no direct interests in the Ordinary Shares of the
Company, however, Mark Hodges and Will Self both participated in
the equity fundraise in respect of the Acquisition, acquiring
150,000 and 50,000 New Ordinary Shares respectively on 4 July
2024.
All of the Directors have interests
in the Company's long term incentive plan, as detailed in Note 18
to the Financial Statements.
James Corsellis is the Chief
Investment Officer of MIM LLP which, at the balance sheet date,
managed 75 per cent. of the Ordinary Shares and matching warrants,
and 100% of the A Shares and matching A Warrants, and 1 sponsor
share. As set out in Note 22 of these Financial Statements, the
Company issued 30,000,000 New Ordinary Shares in respect of the
Acquisition and the 12,000,000 A shares in issue were converted to
Ordinary Shares and matching A Warrants were redeemed and
cancelled. As a result, as at the date of this report MIM LLP
manages 68.4% of the Company's Ordinary Shares and 1 sponsor share.
MIM LLP's ordinary shareholding will fall to 59.8% upon issue of
the Consideration Shares at Completion. James Corsellis is also the
managing partner of Marwyn Capital LLP, a firm which provides
corporate finance advice, company secretarial services and ad-hoc
managed services support to the Company.
Details of the related party
transactions which occurred during the year are disclosed in Note
19 to the Financial Statements, save for the participation in the
Company's long term incentive plan as disclosed in Note 18 to the
Financial Statements.
There were no loans or guarantees
granted or provided by the Company and/or any of its subsidiaries
to or for the benefit of any of the Directors.
Statement of Going Concern
The Financial Statements have been
prepared on a going concern basis, which assumes that the Group
will continue to be able to meet its liabilities as they fall due.
The Directors have considered the financial position of the Group
and have reviewed forecasts and budgets for a period of at least 12
months following the approval of the Financial Statements, and, in
respect of the Acquisition and publication of the Prospectus, and
the application to the FCA in respect of change in control
approval, the Company looked at a period of three years following
Completion.
At 30 June 2024, the Group has net
assets of £1,832,896 (2023: £4,749,829), net assets excluding
warrant liabilities of £3,920,896 (2023: £7,416,829) and a cash
balance of £6,461,475 (2023: £7,783,448). As disclosed in more
detail in note 22 of these Financial Statements, on the 4th July
2024, the Company raised £30,000,000 through the placing of
30,000,000 New Ordinary Shares, at a price of £1 per share and the
net proceeds from the placing were received into the Company's bank
account on this date.
Should Completion not occur, the
Company has sufficient resources to continue to pursue its
investment strategy which may include effecting a merger, share
exchange, asset acquisition, share or debt purchase, reorganisation
or similar business combination with one or more businesses. Should
Completion occur, the Company has sufficient resources to complete
the Acquisition and operate the Enlarged Group.
The Directors have considered macro
environmental factors that have impacted both the global and
domestic economy, in making their assessment of the Company's
ability to continue as a going concern both with, and without
Completion occurring.
Based on their review the Directors
have concluded that there are no material uncertainties relating to
going concern status of the Group and as such the Financial
Statements have been prepared on a going concern basis, which
assumes that the Group will continue to be able to meet its
liabilities as they fall due within the next 12 months from the
date of approval of the Financial Statements.
Outlook
Subject to Completion, the
acquisition of InvestAcc provides an excellent platform from which
to execute a buy and build strategy in the pensions administration
sector. We have long admired InvestAcc Group, which has a strong
market reputation and a loyal and growing customer base.
With a greater focus on savings,
changing demographics and a growing reliance on the family, the
pensions administration industry plays an important role in
securing financial independence and security for customers over the
long-term.
The Company has appointed Allan
Dibble as Chief Commercial Officer ("CCO"), and subject to regulatory
approval he will commence his role in September 2024. Allan brings
over 20 years of experience in post-merger integration and
strategic transformation in financial services, primarily in the
life insurance, savings and retirement sectors. Allan's expertise
will prove invaluable as we look forward to investing further in
InvestAcc's proposition and unlocking an ambitious M&A agenda
to build the UK's leading specialist pensions
administrator.
In addition, James Keely was
appointed as Chief Risk Officer on 20 August 2024. He had worked
closely with the Directors, supporting the Company with the
Acquisition and subsequent FCA application as a consultant. James
was Chief Risk Officer at Curtis Banks Group plc until January
2024. James was the FCA approved person for Risk, Compliance
and the Money Laundering Reporting Officer for the regulated
entities within the Curtis Banks Group, three FCA approved pension
providers and a PRA/FCA dual regulated insurance company. He has
over twenty years of experience in senior risk, governance and
regulatory roles within the financial services sector, including
significant involvement in various mergers and acquisitions of
pension providers.
The Board has a number of active
conversations in respect of potential opportunities in progress and
we look forward to updating shareholders in due course.
RESPONSIBILTY STATEMENT
The Directors are responsible for
preparing the consolidated financial statements in accordance with
applicable laws and regulations, including
the BVI Business Companies Act, 2004. The Directors have prepared
the financial statements for the year to 30 June 2024, which
present fairly the state of affairs of the Group and the profit or
loss of the Group for that year.
The Directors have acted honestly
and in good faith and in what the Directors believes to be in the
best interests of the Company.
The Directors have chosen to use
International Financial Reporting Standards as adopted by the
European Union ("EU adopted
IFRS" or "IFRS") in
preparing the Group's Financial Statements. International
Accounting Standard 1 requires that the Financial Statements
present fairly for each financial year the group's financial
position, financial performance and cash flows. This requires the
faithful presentation of the effects of transactions, other events
and conditions in accordance with the definitions and recognition
criteria for assets, liabilities, income and expenses set out in
the International Accounting Standards Board's "Framework for the
preparation and presentation of financial statements". In virtually
all circumstances, a fair presentation will be achieved by
compliance with all applicable EU adopted IFRS.
A fair presentation also requires
the Directors to:
· select
consistently and apply appropriate accounting policies;
· present information, including accounting policies, in a
manner that provides relevant, reliable, comparable and
understandable information;
· make
judgements and accounting estimates that are reasonable and
prudent;
· provide additional disclosures when compliance with the
specific requirements in EU adopted IFRS is insufficient to enable
users to understand the impact of particular transactions, other
events and conditions on the entity's financial position and
financial performance;
· state
that the Group has complied with EU adopted IFRS, subject to any
material departures disclosed and explained in the financial
statements; and
· prepare the Financial Statements on the going concern basis
unless it is inappropriate to presume that the Company will
continue in business.
The Directors are also required to
prepare financial statements in accordance with the rules of the
London Stock Exchange for companies trading securities on the Stock
Exchange.
The Directors are responsible for
keeping proper accounting records which disclose with reasonable
accuracy at any time the financial position of the Group, for
safeguarding the assets, for taking reasonable steps for the
prevention and detection of fraud and other irregularities and for
the preparation of financial statements.
Financial information is published
on the Group's website. The maintenance and integrity of this
website is the responsibility of the Directors; the work carried
out by the auditor does not involve consideration of these matters
and, accordingly, the auditor's accept no responsibility for any
changes that may occur to the Financial Statements after they are
presented initially on the website. Legislation in the British
Virgin Islands governing the preparation and dissemination of
financial statements may differ from legislation in other
jurisdictions.
Directors' Responsibilities Pursuant to DTR4
In compliance with the Listing Rules
of the London Stock Exchange, the Directors confirm to the best of
their knowledge:
· The
Financial Statements have been prepared in accordance with EU
adopted IFRS, and give a true and fair view of the assets,
liabilities, financial position and profit and loss of the Group;
and
· The
management report includes a fair review of the development and
performance of the business and the financial position of the
group, together with a description of the principal risks and
uncertainties that they face.
Independent Auditor
Baker Tilly Channel Islands Limited
("BTCI") remains the
Company's independent auditor for the year ended 30 June 2024 and
has expressed its willingness to continue to act as auditor to the
Group.
Disclosure of Information to Auditor
Each of the Directors in office at
the date the Report of the Directors is approved, whose names and
functions are listed in the Report of the Directors, confirm that,
to the best of their knowledge:
• the
Financial Statements, which have been prepared in accordance with
EU adopted IFRS, present fairly the assets, liabilities, financial
position and loss of the Group;
• the
Report of the Directors includes a fair review of the development
and performance of the business and the position of the Group and
Company, together with a description of the principal risks and
uncertainties that it faces;
• so far
as they are aware, there is no relevant audit information of which
the Group's auditor is unaware; and
• they
have taken all the steps that they ought to have taken as a
Director in order to make themself aware of any relevant audit
information and to establish that the Group's auditor is aware of
that information.
This Directors' Report was approved
by the Board of Directors on 30 August 2024 and is signed on its
behalf.
By Order of the Board
Mark Hodges
Chair
30 August 2024
INDEPENDENT AUDITOR'S REPORT
Independent auditor's report to the members of Marwyn
Acquisition Company II Limited
Opinion
We have audited the consolidated
financial statements of Marwyn Acquisition Company II Limited (the
'Company') and its subsidiaries (together the 'Group'), which
comprise the consolidated statement of financial position as at 30
June 2024, and the consolidated statement of comprehensive income,
consolidated statement of changes in equity and consolidated
statement of cash flows for the year then ended, and notes to the
consolidated financial statements, including a summary of
significant accounting policies.
In our opinion, the accompanying
consolidated financial statements:
· give a
true and fair view of the consolidated financial position of the
Group as at 30 June 2024, and of its consolidated financial
performance and its consolidated cash flows for the year then ended
in accordance with International Financial Reporting Standards as
adopted by the European Union (IFRSs); and
· have
been prepared in accordance with the requirements of the BVI
Business Company Act 2004, as amended.
Basis for Opinion
We conducted our audit in accordance
with International Standards on Auditing (UK) (ISAs) and applicable
law. Our responsibilities under those standards are further
described in the Auditor's Responsibilities for the Audit of the
Consolidated Financial Statements section of our report. We are
independent of the Group in accordance with the ethical
requirements that are relevant to our audit of the consolidated
financial statements in Jersey, including the FRC's Ethical
Standard, and we have fulfilled our other ethical responsibilities
in accordance with these requirements. We believe that the audit
evidence we have obtained is sufficient and appropriate to provide
a basis for our opinion.
Key
Audit Matters
Key audit matters are those matters
that, in our professional judgement, were of most significance in
our audit of the consolidated financial statements of the current
period and include the most significant assessed risks of material
misstatement (whether or not due to fraud) identified by us,
including those which had the greatest effect on: the overall audit
strategy; the allocation of resources in the audit; and directing
the efforts of the engagement team. These matters were addressed in
the context of our audit of the consolidated financial statements
as a whole, and in forming our opinion thereon, and we do not
provide a separate opinion on these matters.
Key
audit matter
|
How
our audit addressed the matter
|
Key
observations communicated to those charged with
governance
|
Equity and Warrants Issuance
The warrants issued to investors are
subject to judgement in both classification and
valuation.
The classification of the warrants
is complex and must consider the nature and details of the
instrument contracts to determine the correct classification
between equity and liabilities.
Further the fair value of these
warrants was determined using the Black Scholes option pricing
methodology which considered the exercise price, expected
volatility, risk free rate, expected dividends and expected term of
the warrants which is complex and involves estimates and
judgements.
Financial statement impact:
£2,088,000 (PY: 2,667,000).
The accounting policies in note 2
sets out the treatment applied by management, and related
disclosures are presented in note 14.
|
Classification
We obtained an understanding of
management's assessment of the classification of these instruments
and the rationale for their classification.
We critically reassessed whether the
facts and circumstances remain unchanged during the current period,
to ensure the classification remained appropriate.
Valuation
We obtained the valuation report
prepared by management's expert and reviewed the credentials and
inputs used.
We reviewed and validated the
assumptions, methodology and calculations in respect of the
valuation of the instruments and confirmed it was in accordance
with the requirements of IFRS 9 and IFRS 13.
We also inspected the scoping
sections of the management expert reports to ensure the procedures
were for the appropriate purpose.
Disclosure
We reviewed the relevant disclosures
in the consolidated financial statements in accordance with the
requirements of the IFRS as adopted by the European Union and
performed a financial statement disclosure checklist utilising
specialist software.
|
Based on the procedures performed,
we are satisfied that management's judgements and estimates in
respect of the valuation and classification of warrants for the
year ended 30 June 2024, along with the related disclosures in the
consolidation financial statements, are appropriate.
We have nothing further to report to
those charged with governance from our testing.
|
Our
Application of Materiality
Materiality for the consolidated
financial statements as a whole was set at £73,000 (PY: £189,000),
determined with reference to a benchmark of net assets, of which it
represents 4% (PY: 4%).
In line with our audit methodology,
our procedures on individual account balances and disclosures were
performed to a lower threshold, performance materiality, so as to
reduce to an acceptable level the risk that individually immaterial
misstatements in individual account balances add up to a material
amount across the consolidated financial statements as a
whole.
Performance materiality was set at
70% (PY: 70%) of materiality for the consolidated financial
statements as a whole, which equates to £51,000 (PY: £132,000). We
applied this percentage in our determination of performance
materiality because we did not identify any factors indicating an
elevated level of risk.
We reported to the Board of
Directors any uncorrected omissions or misstatements exceeding
£3,600 (PY: £9,400), in addition to those that warranted reporting
on qualitative grounds.
The work on all the components was
performed by the Group audit team.
Conclusions relating to Going Concern
In auditing the consolidated
financial statements, we have concluded that the Directors' use of
the going concern basis of accounting in the preparation of the
consolidated financial statements is appropriate.
Based on the work we have performed,
we have not identified any material uncertainties relating to
events or conditions that, individually or collectively, may cast
significant doubt on the Group's ability to continue as a going
concern for a period of at least twelve months from when the
consolidated financial statements are authorised for
issue.
Our responsibilities and the
responsibilities of the Directors with respect to going concern are
described in the relevant sections of this report.
Other Information
The other information comprises the
information included in the annual report other than the
consolidated financial statements and our auditor's report thereon.
The Directors are responsible for the other information contained
within the annual report. Our opinion on the consolidated financial
statements does not cover the other information and, except to the
extent otherwise explicitly stated in our report, we do not express
any form of assurance conclusion thereon. Our responsibility is to
read the other information and, in doing so, consider whether the
other information is materially inconsistent with the consolidated
financial statements or our knowledge obtained in the course of the
audit, or otherwise appears to be materially misstated. If we
identify such material inconsistencies or apparent material
misstatements, we are required to determine whether this gives rise
to a material misstatement in the consolidated financial statements
themselves. If, based on the work performed, we conclude that there
is a material misstatement of this other information, we are
required to report that fact.
We have nothing to report in this
regard.
Responsibilities of the Directors
As explained more fully in the
Directors' responsibilities statement set out on page 9 and 10, the
Directors are responsible for the preparation of consolidated
financial statements that give a true and fair view in accordance
with IFRSs, and for such internal control as the Directors
determine is necessary to enable the preparation of consolidated
financial statements that are free from material misstatement,
whether due to fraud or error.
In preparing the consolidated
financial statements, the Directors are responsible for assessing
the Group's ability to continue as a going concern, disclosing, as
applicable, matters related to going concern and using the going
concern basis of accounting unless management either intends to
liquidate the Company or to cease operations, or has no realistic
alternative but to do so.
The Directors are responsible for
overseeing the Group's financial reporting process.
Auditor's Responsibilities for the Audit of the Consolidated
Financial Statements
Our objectives are to obtain
reasonable assurance about whether the consolidated financial
statements as a whole are free from material misstatement, whether
due to fraud or error, and to issue an auditor's report that
includes our opinion. Reasonable assurance is a high level of
assurance, but is not a guarantee that an audit conducted in
accordance with ISAs will always detect a material misstatement
when it exists. Misstatements can arise from fraud or error and are
considered material if, individually or in the aggregate, they
could reasonably be expected to influence the economic decisions of
users taken on the basis of these consolidated financial
statements.
The extent to which our procedures
are capable of detecting irregularities, including fraud, is
detailed below:
· Enquiry of management to identify any instances of
non-compliance with laws and regulations, including actual,
suspected or alleged fraud;
· Reading minutes of meetings of the Board of
Directors;
· Review
of legal invoices;
· Review
of management's significant estimates and judgements for evidence
of bias;
· Review
for undisclosed related party transactions;
· Obtained and reviewed bank statements as well as reviewed
ledgers and minutes to ensure finance income is complete and as per
our expectations;
· Using
analytical procedures to identify any unusual or unexpected
relationships; and
· Undertaking journal testing, including an analysis of manual
journal entries to assess whether there were large and/or unusual
entries pointing to irregularities, including fraud.
The Company is required to include
these financial statements in an annual financial report prepared
using the single electronic reporting format specified in the TD
ESEF Regulation. The auditor's report provides no assurance over
whether the annual financial report has been prepared in accordance
with that format.
A further description of the
auditor's responsibilities for the audit of the financial
statements is located at the Financial Reporting Council's website
at www.frc.org.uk/auditorsresponsibilities.
This description forms part of our
auditor's report.
Other Matters which we are Required to
Address
We were appointed by Marwyn
Acquisition Company II Limited to audit the consolidated financial
statements. Our total uninterrupted period of engagement is 3
years.
The non-audit services prohibited by
the FRC's Ethical Standard were not provided to the Group and we
remain independent of the Group in conducting our audit. Our audit
opinion is consistent with the additional report to the board in
accordance with ISAs.
Use
of this Report
This report is made solely to the
Members of the Company, as a body, in accordance with our letter of
engagement dated 24 July 2024. Our audit work has been undertaken
so that we might state to the Members those matters we are required
to state to them in an auditor's report and for no other purpose.
To the fullest extent permitted by law, we do not accept or assume
responsibility to anyone other than the Company and its Members, as
a body, for our audit work, for this report, or for the opinions we
have formed.
Sandy Cameron
For
and on behalf of Baker Tilly Channel Islands
Limited
Chartered Accountants
St Helier, Jersey
Date: 30 August 2024
CONSOLIDATED STATEMENT OF COMPREHENSIVE
INCOME
|
|
Year
ended
30 June
2024
|
|
Year
ended
30 June
2023
|
|
Note
|
£'s
|
|
£'s
|
|
|
|
|
|
Administrative expenses
|
6
|
(3,909,470)
|
|
(3,526,278)
|
Total operating loss
|
|
(3,909,470)
|
|
(3,526,278)
|
|
|
|
|
|
Finance income
|
7
|
359,367
|
|
252,379
|
Movement in fair value of
warrants
|
14
|
579,000
|
|
(254,000)
|
Loss for the year before tax
|
|
(2,971,103)
|
|
(3,527,899)
|
|
|
|
|
|
Income tax
|
8
|
-
|
|
-
|
Loss for the year
|
|
(2,971,103)
|
|
(3,527,899)
|
Total other comprehensive
income
|
|
-
|
|
-
|
Total comprehensive loss for the year
|
|
(2,971,103)
|
|
(3,527,899)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per ordinary share
|
|
£'s
|
|
£'s
|
Basic and diluted
|
9
|
(0.2339)
|
|
(0.2778)
|
The Group's activities derive from
continuing operations.
The Notes on pages 19
to 37 form an integral part of these Financial
Statements.
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
|
|
As at
30 June
2024
|
|
As at
30 June
2023
|
Assets
|
Note
|
£'s
|
|
£'s
|
|
|
|
|
|
Current assets
|
|
|
|
|
Other receivables
|
11
|
1,069,959
|
|
235,620
|
Cash and cash equivalents
|
12
|
6,461,475
|
|
7,783,448
|
Total current assets
|
|
7,531,434
|
|
8,019,068
|
|
|
|
|
|
Total assets
|
|
7,531,434
|
|
8,019,068
|
|
|
|
|
|
|
|
|
|
|
Equity and liabilities
|
|
|
|
|
Equity
|
|
|
|
|
Ordinary Shares
|
15
|
326,700
|
|
326,700
|
A Shares
|
15
|
10,320,000
|
|
10,320,000
|
Sponsor share
|
15
|
1
|
|
1
|
Share-based payment
reserve
|
16,18
|
255,811
|
|
201,641
|
Accumulated losses
|
16
|
(9,069,616)
|
|
(6,098,513)
|
Total equity
|
|
1,832,896
|
|
4,749,829
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
Trade and other payables
|
13
|
3,610,538
|
|
602,239
|
Warrants
|
14
|
2,088,000
|
|
2,667,000
|
Total liabilities
|
|
5,698,538
|
|
3,269,239
|
|
|
|
|
|
Total equity and liabilities
|
|
7,531,434
|
|
8,019,068
|
The Notes on pages 19
to 37 form an integral part of these Financial
Statements.
The Financial Statements were issued
and approved by the Board of Directors on 30 August
2024 and were signed on
its behalf by:
Mark Hodges
Chair
|
James Pearce
Director
|
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
|
Note
|
Ordinary
Shares
|
A Shares
|
Sponsor
Share
|
Share based payment
reserve
|
Accumulated
losses
|
Total
equity
|
|
|
£'s
|
£'s
|
£'s
|
£'s
|
£'s
|
£'s
|
Balance at 1 July 2022
|
|
326,700
|
10,320,000
|
1
|
171,129
|
(2,570,614)
|
8,247,216
|
Total comprehensive loss for the
year
|
|
-
|
-
|
-
|
-
|
(3,527,899)
|
(3,527,899)
|
Share-based payment
charge
|
18
|
-
|
-
|
-
|
30,512
|
-
|
30,512
|
Balance at 30 June 2023
|
|
326,700
|
10,320,000
|
1
|
201,641
|
(6,098,513)
|
4,749,829
|
|
Note
|
Ordinary
Shares
|
A Shares
|
Sponsor
Share
|
Share based payment
reserve
|
Accumulated
losses
|
Total
equity
|
|
|
£'s
|
£'s
|
£'s
|
£'s
|
£'s
|
£'s
|
Balance at 1 July 2023
|
|
326,700
|
10,320,000
|
1
|
201,641
|
(6,098,513)
|
4,749,829
|
Total comprehensive loss for the
year
|
|
-
|
-
|
-
|
-
|
(2,971,103)
|
(2,971,103)
|
Share-based payment
charge
|
18
|
-
|
-
|
-
|
43,510
|
-
|
43,510
|
Issuance of A1 incentive
shares
|
18
|
-
|
-
|
-
|
10,660
|
-
|
10,660
|
Balance at 30 June 2024
|
|
326,700
|
10,320,000
|
1
|
255,811
|
(9,069,616)
|
1,832,896
|
The Notes on pages 19
to 37 form an integral part of these Financial
Statements.
CONSOLIDATED STATEMENT OF CASH FLOWS
|
|
Year ended
30 June
|
|
Year ended
30 June
|
|
|
2024
|
|
2023
|
|
Note
|
£'s
|
|
£'s
|
Operating activities
|
|
|
|
|
Loss for the year
|
|
(2,971,103)
|
|
(3,527,899)
|
|
|
|
|
|
Adjustments to reconcile total operating loss to net cash
flows:
|
|
|
|
|
Finance income
|
7
|
(359,367)
|
|
(252,379)
|
Fair value (gain) / loss on warrant
provision
|
14
|
(579,000)
|
|
254,000
|
Share-based payment
expense
|
18
|
43,510
|
|
30,512
|
Working capital adjustments:
|
|
|
|
|
(Increase) / decrease in other
receivables
|
11
|
(834,339)
|
|
569,740
|
Increase in trade and other
payables
|
13
|
2,385,231
|
|
184,497
|
Net
cash flows used in operating activities
|
|
(2,315,068)
|
|
(2,741,529)
|
|
|
|
|
|
Investing activities
|
|
|
|
|
Interest received
|
7
|
359,367
|
|
252,379
|
Net
cash flows received from investing activities
|
|
359,367
|
|
252,379
|
|
|
|
|
|
Financing activities
|
|
|
|
|
Proceeds from issue of ordinary A
share capital in MAC II (BVI) Ltd
|
18
|
10,660
|
|
18,400
|
Proceeds from proposed placing and
subscription of Ordinary Shares
|
13,
22
|
623,068
|
|
-
|
Net
cash flows received from financing activities
|
|
633,728
|
|
18,400
|
|
|
|
|
|
Net decrease in cash and cash
equivalents
|
|
(1,321,973)
|
|
(2,470,750)
|
Cash and cash equivalents at the
beginning of the year
|
|
7,783,448
|
|
10,254,198
|
Cash and cash equivalents at the end of the
year
|
12
|
6,461,475
|
|
7,783,448
|
The Notes on pages 19
to 37 form an integral part of these Financial
Statements.
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS
1. GENERAL
INFORMATION
Marwyn Acquisition Company II
Limited (the "Company") was
incorporated on 31 July 2020 in the British Virgin Islands
("BVI") as a BVI business
company (registered number 2040956) under the BVI Business Company
Act, 2004. The Company was listed on the Main Market of the London
Stock Exchange on 4 December 2020 and has its registered address at
Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola,
VG1110, British Virgin Islands and UK establishment (BR022831) at
11 Buckingham Street, London WC2N 6DF.
The Company was formed for the
purpose of effecting a merger, share exchange, asset acquisition,
share or debt purchase, reorganisation or similar business
combination with one or more businesses. The Company has two
subsidiaries, MAC II (BVI) Limited and MAC II UK Limited (together
with the Company, the "Group").
As set out in the Management Report,
the Company announced on 28 June 2024 that it had entered into
binding agreements to acquire 100% of the issued share capital of
InvestAcc Group Limited. The Acquisition is
partly funded via a £30 million institutional
placing and subscription (effective 4th July 2024) and
the issue of 6,150,911 Consideration Shares.
2. MATERIAL ACCOUNTING
POLICIES
(a) Basis of preparation
The Financial Statements for the
year ended 30 June 2024 have been prepared in accordance with International Financial Reporting Standards
and IFRS Interpretations Committee interpretations as adopted by
the European Union (collectively, "EU adopted IFRS" or
"IFRS") and are presented in British pounds sterling, which is the
presentational currency of the Group. The Financial Statements have
been prepared under the historical cost basis, except for the
revaluation of certain financial instruments that will be measured
at fair value at the end of each reporting year, as explained in
the accounting policies below.
The principal accounting policies
adopted in the preparation of the Financial Statements are set out
below. The policies have been consistently applied throughout the
current and prior year presented.
(b) Going concern
The Financial Statements have been
prepared on a going concern basis, which assumes that the Group
will continue to be able to meet its liabilities as they fall due.
The Directors have considered the financial position of the Group
and have reviewed forecasts and budgets for a period of at least 12
months following the approval of the Financial Statements, and, in
respect of the Acquisition and publication of the Prospectus, and
the application to the FCA in respect of change in control
approval, the Company looked at a period of three years following
Completion.
At 30 June 2024, the Group has net
assets of £1,832,896 (2023: £4,749,829), net assets excluding
warrant liabilities of £3,920,896 (2023: £7,416,829) and a cash
balance of £6,461,475 (2023: £7,783,448). As disclosed in more
detail in note 22 of these Financial Statements, on the 4th July
2024, the Company raised £30,000,000 through the placing of
30,000,000 New Ordinary Shares, at a price of £1 per share and the
net proceeds from the placing were received into the Company's bank
account on this date.
Should Completion not occur, the
Company has sufficient resources to continue to pursue its
investment strategy which may include effecting a merger, share
exchange, asset acquisition, share or debt purchase, reorganisation
or similar business combination with one or more businesses. Should
Completion occur, the Company has sufficient resources to complete
the Acquisition and operate the Enlarged Group.
The Directors have considered macro
environmental factors that have impacted both the global and
domestic economy, in making their assessment of the Company's
ability to continue as a going concern both with, and without
Completion occurring.
Based on their review the Directors
have concluded that there are no material uncertainties relating to
going concern status of the Group and as such the Financial
Statements have been prepared on a going concern basis, which
assumes that the Group will continue to be able to meet its
liabilities as they fall due within the next 12 months from the
date of approval of the Financial Statements.
(c) New standards and amendments to
International Financial Reporting Standards
Standards, amendments and interpretations issued but not yet
effective:
The following standards are issued
but not yet effective. The Group intends to adopt these standards,
if applicable, when they become effective. It is not currently
expected that these standards will have a material impact on
the Group.
Standard
|
Effective
date
|
Amendments to IAS 7 and IFRS 7
Supplier Finance Arrangements;
|
1 January
2024
|
Amendments to IAS 1 Non-current
Liabilities with Covenants;
|
1 January
2024
|
Amendment to IFRS 16 Leases: Lease
Liability in a sale & leaseback;
|
1 January
2024
|
Amendments to IAS 1 Presentation of
Financial Statements: Classification of Liabilities as Current or
Non-current*;
|
1 January
2024
|
Amendments to IAS 21 Lack of
exchangeability*;
|
1 January
2025
|
Amendments IFRS 9 and IFRS 7
regarding the classification and measurement of financial
instruments*; and
|
1 January
2026
|
IFRS 18 - Presentation and
Disclosure of financial Statements*.
|
1 January
2027
|
* Subject to EU
endorsement
|
|
(d) Basis of consolidation
Subsidiaries are entities controlled
by the Company. Control exists when the Company is exposed to, or
has rights to, variable returns from its involvement with the
entity and has the ability to affect those returns through its
power over the entity. The financial information of subsidiaries is
fully consolidated from the date that control commences until the
date that control ceases.
Intragroup balances, and any gains
and losses or income and expenses arising from intragroup
transactions, are eliminated in preparing the consolidated
financial information.
(e) Financial instruments
A financial instrument is any
contract that gives rise to a financial asset of one entity and a
financial liability or equity instrument of another
entity.
The Group initially recognises
financial assets and financial liabilities at fair value. With the
exception of warrants, financial assets and liabilities are
subsequently remeasured at amortised cost using the effective
interest rate.
Warrants
Warrants are accounted for as
derivative liability instruments under IAS 32 and are measured at
fair value at the date of issue and remeasured at each subsequent
reporting date with changes in fair value being recognised in the
Statement of Comprehensive Income. Fair value of the warrants has
been calculated using a Black-Scholes option pricing methodology
and details of the estimates and judgements used in determining the
fair value of the warrants are set out in Note 3. The warrant
liability will be derecognised when the liability is extinguished
either through exercise, expiry or surrender.
(f) Cash and cash
equivalents
Cash and cash equivalents comprise
cash balances and demand deposits at banks. All deposits are
readily convertible to known amounts of cash and which are subject
to an insignificant risk of change with a short maturity of less
than 2 months.
(g) Equity
Ordinary shares, A shares and sponsor
shares are classified as equity. Incremental costs directly attributable to the issue of new
shares are recognised in equity as a deduction from the
proceeds.
(h) Corporation tax
Corporation tax for the year
presented comprises current and deferred tax.
Current tax is the expected tax
payable on the taxable income for the year, using tax rates enacted
or substantially enacted at the balance sheet date. Deferred tax is
provided using the balance sheet liability method, providing for
temporary differences between the carrying amounts of assets and
liabilities for financial reporting purposes and the amounts used
for taxation purposes. A deferred tax asset is recognised only to
the extent that it is probable that future taxable profits will be
available against which the asset can be utilised.
(i) Loss per ordinary
share
The Group presents basic earnings per
Ordinary Share ("EPS") data
for its Ordinary Shares and A Shares as disclosed in more detail in
Note 9. Basic EPS is calculated by dividing the profit or loss
attributable to ordinary shareholders of the Company by the
weighted average number of Ordinary Shares outstanding during the
year. Diluted EPS is calculated by adjusting the weighted average
number of Ordinary Shares outstanding to assume conversion of all
potential dilutive Ordinary Shares.
(j) Share based
payments
The A1 Ordinary Shares and A2
Ordinary Shares in MAC II (BVI) Limited (the "Incentive Shares''), represent
equity-settled share-based payment arrangements under which the
Group receives services as a consideration for the additional
rights attached to these equity shares.
Equity-settled share-based payments
to Directors and others providing similar services are measured at
the fair value of the equity instruments at the grant date. Fair
value is determined using an appropriate valuation technique,
further details of which are given in Note 18. The fair value is
expensed, with a corresponding increase in equity, on a
straight-line basis from the grant date to the expected exercise
date. Where the equity instruments granted are considered to vest
immediately as the services are deemed to have been received in
full, the fair value is recognised as an expense with a
corresponding increase in equity recognised at grant
date.
(k) Warrants
On 4 December 2020, the Company
issued 700,000 Ordinary Shares and matching warrants
at a price of £1 for one ordinary share and
matching warrant. Under the terms of the
warrant instrument, warrant holders are able to acquire one
ordinary share per warrant at a price of £1 per ordinary share,
subject to a downward price adjustment depending on future share
issues.
On 20 April 2021, the Company issued
12,000,000 A shares and matching A warrants at a price of £1 for
one ordinary A share and matching A warrant. Under the terms of the warrant instrument, warrant holders are
able to acquire one ordinary share per warrant at a price of £1 per
ordinary share, subject to a downward price adjustment depending on
future share issues.
As set out in note 22 of these
Financial Statements, on the 4 July 2024, the A shares were
converted into Ordinary Shares and the matching A warrants were
surrendered and cancelled.
Warrants are accounted for as
derivative liability instruments under IAS 32 and are measured at
fair value at the date of issue and each subsequent balance sheet
date. Fair value of the warrants has been calculated using a
Black-Scholes option pricing methodology and details of the
estimates and judgements used in determining the fair value of the
warrants are set out in Note 3.
3. CRITICAL ACCOUNTING
JUDGEMENTS AND KEY SOURCES OF ESTIMATION
UNCERTAINTY
The preparation of the Group's
Financial Statements under IFRS requires the Directors to make
estimates and assumptions that affect the reported amounts of
assets and liabilities and the disclosure of contingent assets and
liabilities. Estimates and judgements are continually evaluated and
are based on historical experience and other factors including
expectations of future events that are believed to be reasonable
under the circumstances. Actual results may differ from these
estimates.
Key
sources of estimation uncertainty
Valuation of
warrants
The Company has issued matching
warrants for both its issues of Ordinary Shares and A shares. For
every share subscribed for, each investor was also granted a
warrant ("Warrant") to
acquire a further share at an exercise price of £1.00 per share
(subject to a downward adjustment under certain conditions).
Effective 31 March 2022, the exercise date for the Warrants was
extended to the 5th anniversary of a business
acquisition, as detailed in Note 14. Consistent with prior years,
the Warrants are valued using the Black-Scholes option pricing
methodology which considers the exercise price, expected
volatility, risk free rate, expected dividends, and expected term
of the Warrants.
As disclosed in note 22, on the 28
June 2024 the Company announced that its subsidiary had entered
into binding agreements to acquire 100% of the issued share capital
of InvestAcc, and that the acquisition would be financed via the
placing of 30 million shares at a price of £1 per share. And on 1
July 2024, the Company published a prospectus, which set out in
detail the nature of the transaction, and the financing mechanics
which included the conversion of the 12 million A shares in issue
into Ordinary Shares and the surrender and subsequent cancellation
of the matching A warrants. On 4 July 2024, the Company announced
the issuance of 30 million New Ordinary Shares at £1 per share, the
conversion of the 12 million A shares in issue into Ordinary Shares
and the cancellation of the A warrants.
Given these activities immediately
prior and post year end, the valuation of the ordinary warrants and
A warrants have been calculated differently at the year
end.
Valuation of ordinary
warrants
For the purposes of valuing the
ordinary warrants, a market value of £1 per ordinary share has been
used, being the price that the New Ordinary Shares were subscribed
for without any matching warrants.
Valuation of A warrants
As the A shares were converted into
Ordinary Shares, and the matching A warrants surrendered and
cancelled on 4 July 2024 it is not appropriate to value the A
shares at £1 at year end, instead, the aggregate value of the A
shares and A warrants have a combined value of £1.
Valuation of Incentive
Scheme
The Company has issued Incentive
Shares as part of the creation of a long-term incentive scheme
which is valued using a Monte Carlo model. This model requires
estimation and judgement surrounding the inputs of exercise price,
expected volatility, risk free rate, expected dividends, and
expected term of the Incentive Shares. The Ordinary A share
liability held, represents the subscription price as there is an
option to redeem the shares for cash in the instance of a good
leaver, at the lower of market value and the subscription
price.
Other disclosures relating to the
Group's exposure to risk and uncertainties in relation to financial
instruments are included in Note 17.
Critical accounting
judgements
Classification of
warrants
The Directors considered the warrants
to represent a derivative liability due to the potential
modification of the exercise price under certain conditions that
the Directors believe could possibly occur. This modification
resulted in the warrants failing the 'fixed for fixed' test, as
outlined in IAS 32 para 16, which is required to be met in order to
recognise the warrants as equity instruments, whereby the Company
would be required to provide a fixed number of shares for a fixed
amount of cash on exercise of the warrants. Accordingly, the
warrants were recognised as derivative liabilities, to be assessed
at each balance sheet date with a review of the underlying inputs
undertaken.
The initial fair value recognised
for the warrants affects the corresponding entry in equity
recognised for the issue of shares as the proceeds are required to
be allocated between equity and liability. This is due to the
proceeds received from the issue of equity deemed to have been
received for both the issue of the shares and the warrants
attached.
Recognition and
classification of costs relating to fundraise
As at the 30 June 2024, the Company
has incurred or accrued £2,621,041 of fees in connection with the
acquisition of InvestAcc. These costs have been accounted for
as follows:
i.
Where they are directly attributable to the issuance of shares,
they are taken as a deduction from equity on the issuance of
equity, and;
ii. Where
they are not directly attributable to the issuance of shares (for
example an acquisition cost or listing cost), they are recorded in
the Statement of Comprehensive Income as an expense.
Consistent with the approach taken in
prior years, costs directly related to the prospectus are
considered directly attributable to the issuance of shares, in this
case being the 30 million New Ordinary Shares issued on 4 July
2024. All other costs associated with the transaction, for example
acquisition related costs or costs associated with the listing of
the New Ordinary Shares and conversion of the A shares into
Ordinary Shares are recorded in the Statement of Comprehensive
Income as an expense. As of 30 June 2024, costs amounting to
£903,127 are considered to be directly attributable to the £30
million equity raise and have therefore been included within Other
Receivables and categorised as deferred costs (refer to Note 11).
As detailed in the Management Report and Note 13, on 4 July 2024
the placing and subscription of 30,000,000 New Ordinary Shares was
completed, and as such, on this date the £903,127 of costs incurred
were taken to equity.
4. SEGMENT
INFORMATION
The Board of Directors is the Group's
chief operating decision-maker. As the Group has not yet acquired
an operating business, the Board of Directors considers the Group
as a whole for the purposes of assessing performance and allocating
resources, and therefore the Group has one reportable operating
segment.
5. EMPLOYEES AND
DIRECTORS
During the year ended 30 June 2024,
the Company had five serving Directors: James Corsellis, Mark
Hodges, Cathryn Riley (resigned 23 May 2024), Will Self and James
Pearce (appointed 23 May 2024). The Company has one employee at the
year-end who was not a director during the year (2023:
One).
Mark Hodges, Cathryn Riley, James
Pearce and Will Self were the only Directors to receive
remuneration under the terms of their director service agreements
during the year.
The Company's subsidiary has issued
Incentive Shares directly to Will Self, James Pearce, and Mark
Hodges. James Corsellis is indirectly beneficially interested in
the Incentive Shares through his interest in MLTI. Further detail
is disclosed in Note 18.
(a) Employment costs for the Group during the
year:
|
Year ended
30 June
2024
|
|
Year ended
30 June
2023
|
|
£'s
|
|
£'s
|
|
|
|
|
Directors' salaries
|
727,045
|
|
322,083
|
Staff salaries
|
118,180
|
|
66,435
|
Social security costs
|
114,803
|
|
57,335
|
Signing on fee
|
-
|
|
34,717
|
Pension contributions
|
29,218
|
|
5,967
|
Short term employee
benefits
|
4,468
|
|
3,604
|
Total employment costs
expense
|
993,714
|
|
490,142
|
On 2 April 2024, James Pearce entered
into a service agreement with the Company. Under the terms of his
service agreement James was appointed as CFO. James is entitled to
an annual gross salary of £220,000, a 5% employer pension
contribution and to a transactional bonus of up to £100,000 on
Completion. Employment is for an initial period of 12 months and in
the event that Completion occurs within a year of James's
appointment, a further 12 month period of employment shall
commence. On 22 May 2024 James Pearce was issued A1 shares for
which vesting will commence on permanent employment. Further
details can be found in Note 18. On 23 May 2024 James Pearce was
appointed as a director of the Company. Between the date of James's
employment commencing, and his appointment as a director of the
Company, James's salary was recorded in staff salaries.
Mark Hodges in respect of his
appointment as Non-Executive Director and Chairman is entitled to
an annual fee of £250,000. In the year ended June 2023 Mark also
received a signing on fee of £61,238 of which £47,000 was used to
pay the subscription price for his Incentive Shares as further
detailed in Note 18 (2024: None).
Cathryn Riley in respect of her
appointment as Non-Executive Director was entitled to an annual fee
of £70,000. Cathryn stepped down from the Board on 23 May
2024.
Will Self in respect of his
appointment as Chief-Executive Officer is entitled to an annual
gross salary of £320,000, employer pension contribution of 8% of
Gross salary and car allowance of up to £10,000. There are
provisions for discretionary annual bonuses to be paid up to the
maximum value of 75% of salary provided performance targets are
met. In the year ended June 2023, he received a signing on fee of
£34,717 of which £18,400 was used to pay the subscription price for
his Incentive Shares as further detailed in Note 18 (2024:
None).
James Corsellis did not receive a fee
for his role as a non-executive director in the current year.
With effect from 4 July 2024, James will be paid a fee of £75,000
per annum.
(b) Key management compensation
During the year, the Board considered
the Directors of the Company to be the key management personnel of
the Group.
(c) Employed persons
The average monthly number of
persons employed by the Group (including Directors) during the year
was as follows:
|
Year ended
30 June
2024
|
|
Year ended
30 June
2023
|
|
number
|
|
number
|
Directors
|
4
|
|
3
|
Other staff
|
1
|
|
-
|
|
5
|
|
3
|
6. ADMINISTRATIVE
EXPENSES
|
Year ended
30 June
2024
|
|
Year
ended
30 June
2023
|
|
£'s
|
|
£'s
|
Group expenses by nature
|
|
|
|
Personnel costs
|
993,714
|
|
490,142
|
Acquisition related costs
|
1,717,914
|
|
-
|
Non-recurring project, professional
and diligence costs
|
115,500
|
|
2,017,600
|
Professional support
|
1,007,269
|
|
955,813
|
Audit fees payable (Note
21)
|
24,580
|
|
23,000
|
Share-based payment expenses (Note
18)
|
43,510
|
|
30,512
|
Sundry expenses
|
6,983
|
|
9,211
|
|
3,909,470
|
|
3,526,278
|
Acquisition related costs are those
fees expensed that were attributable to the Acquisition.
In the prior year ending 30 June
2023, included within non-recurring project, professional and
diligence costs is £723,592 that had been
included on the balance sheet within current assets as a deferred
cost in the year ended 30 June 2022. These are costs that were
directly attributable to a future issuance of shares under a
placing programme and therefore expected to be capitalised to
equity, at the point that shares were issued. Effective on 31 March
2023, the Directors approved the termination of that placing
programme and as such, the £723,592 of
costs were taken to the Company's Profit and Loss Account in
non-recurring project, professional and diligence costs.
7. FINANCE
INCOME
|
Year ended
30 June
2024
|
|
Year ended
30 June
2023
|
|
£'s
|
|
£'s
|
|
|
|
|
Interest on bank deposits
|
359,367
|
|
252,379
|
|
359,367
|
|
252,379
|
8. INCOME
TAX
|
|
Year ended
30 June
2024
|
|
Year ended
30 June
2023
|
|
|
£'s
|
|
£'s
|
Analysis of tax in year
|
|
|
|
|
Current tax on loss for the
year
|
|
-
|
|
-
|
Total current tax
|
|
-
|
|
-
|
Reconciliation of effective rate and
tax charge
|
|
Year ended
30 June
2024
|
|
Year ended
30 June
2023
|
|
|
£'s
|
|
£'s
|
|
|
|
|
|
Loss on ordinary activities before
tax
|
|
(2,971,103)
|
|
(3,527,899)
|
Capital allowances
|
|
(758)
|
|
-
|
Expenses not deductible for tax
purposes
|
|
(103,643)
|
|
294,032
|
Loss on ordinary activities subject
to corporation tax
|
|
(3,075,504)
|
|
(3,233,867)
|
Loss multiplied by the rate of
corporation tax in the UK of 25% (2023: 25%)
|
|
(768,876)
|
|
(808,467)
|
Effects of:
|
|
|
|
|
Tax losses not utilised
|
|
768,876
|
|
808,467
|
Total taxation charge
|
|
-
|
|
-
|
The Group is tax resident in the UK.
As at 30 June 2024, cumulative tax losses available to carry
forward against future trading profits were £6,831,237 (2023:
£3,755,735) subject to agreement with HM Revenue & Customs.
There is currently no certainty as to future profits and no
deferred tax asset is recognised in relation to these carried
forward losses. A deferred tax asset will be recognised in
accordance IAS 12 once it is probable that the tax losses can be
utilised. Under UK Law, there is no expiry for the use of tax
losses. The tax losses available as at 30 June 2023 were reported
as £4,953,146 in the prior year annual report. Subsequent to
publication of those accounts, an update was made to the taxation
calculation in line with updated professional tax advice, resulting
in an adjustment to the losses available to carry
forward.
9. LOSS PER ORDINARY
SHARE
Basic EPS is calculated by dividing
the loss attributable to equity holders of the company by the
weighted average number of Ordinary Shares and A shares in issue
during the year. Diluted EPS is calculated
by adjusting the weighted average number of Ordinary Shares and A
shares outstanding to assume conversion of all dilutive potential
Ordinary Shares and A shares. The Company being loss making in both
this year and comparative year would mean that any exercise would
be anti-dilutive.
The Company maintains different
share classes, of which Ordinary Shares, A shares and sponsor
shares were in issue in the current year and prior year. The key
difference between Ordinary Shares and A shares is that the
Ordinary Shares are traded with voting rights attached. The
ordinary share and A share classes both have equal rights to the
residual net assets of the Company, which enables them to be
considered collectively as one class per the provisions of IAS 33.
The sponsor share has no rights to distribution rights so has been
ignored for the purposes of IAS 33.
Immediately prior to the year end,
the Company entered into Placing and Subscription agreements for
the allotment of 30 million New Ordinary Shares, these shares were
issued on 4 July. On the same date, the 12 million A shares
were converted into Ordinary Shares and the 12 million A warrants
were redeemed and cancelled. These new ordinary shares and
converted A shares represent Ordinary Shares for the purposes of
the loss per share calculation from their date of issuance, 4 July
2024 which will be reflected in the EPS calculation presented in
the Company's interim accounts for the period to 31 December
2024.
Refer to Note 14 (warrant liability)
and Note 18 (share-based payments) for instruments that could
potentially dilute basic EPS in the future.
|
Year ended
30 June
2024
|
|
Year ended
30 June
2023
|
Loss attributable to owners of the
parent (£'s)
|
(2,971,103)
|
|
(3,527,899)
|
|
|
|
|
Weighted average in issue
|
12,700,000
|
|
12,700,000
|
Basic and diluted loss per ordinary
share (£'s)
|
(0.2339)
|
|
(0.2778)
|
10. SUBSIDIARY
Marwyn Acquisition Company II
Limited is the parent company of the Group, the Group comprises of
Marwyn Acquisition Company II Limited and the following
subsidiaries as at 30 June 2024:
Company name
|
Nature of
business
|
Country of
incorporation
|
Ordinary Shares held directly
by parent
|
MAC II (BVI) Limited
|
Incentive
vehicle
|
British
Virgin Islands
|
100%
|
MAC II UK Limited
|
Holding
Company
|
England
|
100%
|
The share capital of MAC II (BVI)
Limited consists of both Ordinary Shares and Incentive Shares. The
Incentive Shares are non-voting and disclosed in more detail in
Note 18.
MAC II UK Limited was incorporated
on 13 May 2024. The registered office of
MAC II UK Limited is 11 Buckingham Street, London, United Kingdom,
WC2N 6DF.
The registered office of MAC II
(BVI) Limited is Commerce House, Wickhams Cay 1, P.O. Box 3140,
Road Town, Tortola, VG1110, British Virgin Islands and has a UK
Establishment address at 11 Buckingham Street, London, WC2N
6DF.
There are no restrictions on the
parent company's ability to access or use the assets and settle the
liabilities of the parent company's subsidiary.
11. OTHER
RECEIVABLES
|
As at
30 June
2024
|
|
As at
30 June
2023
|
|
£'s
|
|
£'s
|
Amounts receivable within one year:
|
|
|
|
Prepayments
|
104,769
|
|
20,689
|
Deferred costs
|
903,127
|
|
-
|
Due from related party (Note
19)
|
1
|
|
1
|
VAT receivable
|
62,062
|
|
214,930
|
|
1,069,959
|
|
235,620
|
An amount of £903,127 (2023: £Nil)
is included in deferred costs as it directly relates to the
potential issuance of share capital and therefore, on issuance of
the New Ordinary Shares on 4 July 2024, was reflected in equity.
Further details are set out in the critical accounting judgements
in Note 3 and under post balance sheet events in Note
22.
There is no material difference
between the book value and the fair value of the receivables.
Receivables are considered to be past due once they have passed
their contracted due date. Other receivables are all
current.
12. CASH AND CASH
EQUIVALENTS
|
|
As at
30 June
2024
|
|
As at
30 June
2023
|
|
|
£'s
|
|
£'s
|
Cash and cash equivalents
|
|
|
|
|
Cash at bank
|
|
6,461,475
|
|
7,783,448
|
|
|
6,461,475
|
|
7,783,448
|
Credit risk is managed on a group
basis. Credit risk arises from cash and cash equivalents and
deposits with banks and financial institutions. For banks and
financial institutions, only independently rated parties with a
minimum short-term credit rating of P-1, as issued by Moody's, are
accepted.
13. TRADE AND
OTHER PAYABLES
|
As at
30 June
2024
|
|
As at
30 June
2023
|
|
£'s
|
|
£'s
|
Amounts falling due within one year:
|
|
|
|
Trade payables
|
376,645
|
|
165,661
|
Due to a related party (Note
19)
|
635,213
|
|
179,192
|
Accruals
|
1,866,209
|
|
158,602
|
Other tax liabilities
|
43,456
|
|
30,345
|
Other creditors
|
623,615
|
|
3,039
|
A1 ordinary share liability (Note
18)
|
65,400
|
|
65,400
|
|
3,610,538
|
|
602,239
|
There is no material difference
between the book value and the fair value of the trade and other
payables.
As at 30 June 2024 other creditors
includes £623,068 (2023: £Nil) in respect of cash received into the
Company's bank account as part of the issuance of 30 million New
Ordinary Shares. These shares were subject to admission no later
than 4 July 2024, and before this point their issue was revocable
by the Company, and as such has been recorded as a liability to the
Company at 30 June 2024.
Accruals includes amounts of
£842,627 for fees payable in respect of the Placing and
Subscription for issue of 30,000,000 New Ordinary Shares on 28 June
2024, and £929,334 in relation to acquisition of InvestAcc. As at
30 June 2024 management deem these fees highly probable and as such
have been recorded as a liability.
All trade payables are non-interest
bearing and are usually paid within 30 days.
14. WARRANT
LIABILITY
|
|
£'s
|
Fair value of warrants at 1 July 2022
|
|
2,413,000
|
Fair value movement of warrants:
Warrant liability - ordinary warrants
|
|
|
Warrant liability - ordinary
warrants
|
|
14,000
|
Warrant liability - A
warrants
|
|
240,000
|
Total fair value movement
|
|
254,000
|
Fair value of warrants at 30 June 2023
|
|
2,667,000
|
|
|
|
Fair value movement of warrants:
Warrant liability - ordinary warrants
|
|
|
Warrant liability - ordinary
warrants
|
|
21,000
|
Warrant liability - A
warrants
|
|
(600,000)
|
Total fair value movement
|
|
(579,000)
|
Fair value of warrants at 30 June 2024
|
|
2,088,000
|
On 4 December 2020, the Company
issued 700,000 Ordinary Shares and matching warrants at a price of
£1 for one ordinary share and matching warrant. Under the terms of
the warrant instrument ("Warrant
Instrument"), warrant holders are able to
acquire one ordinary share per warrant at a price of £1 per
ordinary share, subject to a downward price adjustment depending on
future share issues prior to or in conjunction with the Company's
Business Acquisition. Warrants are fully vested and are exercisable
for 5 years from the date of the Business Acquisition.
On 20 April 2021, the Company issued
12,000,000 A shares and matching warrants at a price of £1 for one
A share and matching A warrant instrument. Under the terms of the A
warrant instrument ("A Warrant
Instrument"), warrant holders are able to acquire one
ordinary share per warrant at a price of £1 per ordinary share,
subject to a downward price adjustment depending on future share
issues. Warrants are fully vested and are exercisable for 5 years
from the date of the Business Acquisition.
Effective 31 March 2022, both the
Warrant Instrument and A Warrant Instrument were amended such that
the long stop date was extended to the fifth anniversary of an
initial acquisition by a member of the Group (which may be in the
form of a merger, share exchange, asset acquisition, share or debt
purchase, reorganisation or similar transaction) of a business
("Business Acquisition").
Previously the warrants were exercisable for 5 years from the date
of issue.
Warrants are accounted for as a
level 3 derivative liability instruments and are measured at fair
value at grant date and each subsequent balance sheet date. The
warrant instruments and A warrant instruments were separately
valued at the date of grant. For both the Warrants and A Warrants,
the combined market value of one share and one Warrant was
considered to be £1, in line with the market price paid by third
party investors. A Black-Scholes option pricing methodology was
used to determine the fair value, which considered the exercise
prices, expected volatility, risk free rate, expected dividends and
expected term.
As set out with the critical
accounting estimates note, a different approach to valuing the
ordinary warrants and A warrants has been used at year end. In
prior years, both the ordinary warrant and Ordinary Share and A
warrant and A share have been valued at a combined price of £1.
However, at the year end, the market value
of £1 per ordinary share has been used, being the price that the
New Ordinary Shares were subscribed for without any matching
warrants. As the A
shares were converted into Ordinary Shares, and the matching A
warrants surrendered and cancelled on 4 July 2024 it is not
appropriate to value the A shares at £1 at year end, instead, the
Company has continued to use an aggregate value of £1 for an A
shares and A warrant.
At 30 June 2024, the fair value of
the Warrant Instrument was assessed as 24p per warrant and the fair
value of the A Warrant Instrument was assessed as 16p per warrant.
The result of change in fair value of the warrants is a fair value
gain of £579,000 (2023: loss of £254,000). The Directors are
responsible for determining the fair value of the warrants at each
reporting date, the underlying calculations are prepared by
Deloitte LLP.
On 4 July 2024, the Company
announced the successful placing of and subscription for 30 million
New Ordinary Shares, at a price of £1 per share. On this date the
Company also announced that the 12,000,000 A Warrants then in issue
has been surrendered and cancelled. See Note 22 for further
details.
The key assumptions used in
determining the fair value of the Warrants are as
follows:
|
As at
30 June
2024
|
|
As at
30 June
2023
|
|
|
|
|
Underlying ordinary share
price
|
£1
|
|
N/A
|
Combined price of ordinary share and
ordinary warrant
|
N/A
|
|
£1
|
Combined price of A share and A
warrant
|
£1
|
|
£1
|
Exercise price
|
£1
|
|
£1
|
Expected volatility
|
30.0%
|
|
30.0%
|
Risk free rate
|
4.10%
|
|
4.70%
|
Expected dividends
|
3.0%
|
|
0.0%
|
Expected term
|
5th
anniversary of the completion of a Business Acquisition
|
|
5th
anniversary of the completion of a Business Acquisition
|
15. STATED
CAPITAL
|
As at
30 June
2024
|
|
As at
30 June
2022
|
Issued and fully paid
|
£'s
|
|
£'s
|
700,000 Ordinary Shares of no par
value
|
326,700
|
|
326,700
|
12,000,000 A shares of no par
value
|
10,320,000
|
|
10,320,000
|
1 sponsor share of no par
value
|
1
|
|
1
|
Total
|
10,646,701
|
|
10,646,701
|
Under the Company's Memorandum of
Association, the Company is authorised to issue an unlimited number
of ordinary shares and 100 Sponsor Shares of no par value, divided
into five classes as follows:
· an
unlimited number of Ordinary Shares without par value
· an
unlimited number of class A ordinary shares without par
value
· an
unlimited number of class B ordinary shares without par
value
· an
unlimited number of class C ordinary redeemable shares without par
value
· 100
Sponsor Shares without par value
The Ordinary Shares and A shares are
entitled to receive a share in any distribution paid by the Company
and a right to a share in the distribution of the surplus assets of
the Company on a winding-up. Only Ordinary Shares have voting
rights attached. The Sponsor Share confers upon the holder no right
to receive notice and attend and vote at any meeting of members, no
right to any distribution paid by the Company and no right to a
share in the distribution of the surplus assets of the Company on a
summary winding-up. Provided the holder of the Sponsor Share holds
directly or indirectly 5 per cent. or more of the issued and
outstanding shares of the Company (of whatever class other than any
Sponsor Shares), they have the right to appoint one director to the
Board.
The Company must receive the prior
consent of the holder of the Sponsor Share, where the holder of the
Sponsor Share holds directly or indirectly 5 per cent. or more of
the issued and outstanding shares of the Company, in order
to:
•
Issue any further Sponsor Shares;
•
issue any class of shares on a non pre-emptive basis where the
Company would be required to issue such share pre-emptively if it
were incorporated under the UK Companies Act 2006 and acting in
accordance with the Pre-Emption Group's Statement of Principles;
or
•
amend, alter or repeal any existing, or introduce any new
share-based compensation or incentive scheme in respect of the
Group; and
•
take any action that would not be permitted (or would only be
permitted after an affirmative shareholder vote) if the Company
were admitted to the Premium Segment of the Official
List.
The Sponsor Share also confers upon
the holder the right to require that: (i) any purchase of Ordinary
Shares; or (ii) the Company's ability to amend the Memorandum and
Articles, be subject to a special resolution of members whilst the
Sponsor (or an individual holder of a Sponsor Share) holds directly
or indirectly 5 per cent. or more of the issued and outstanding
shares of the Company (of whatever class other than any Sponsor
Shares) or are a holder of Incentive Shares.
As set out in note 22, the A shares
were converted into Ordinary Shares effective 4 July 2024 and
therefore at the date of this report, the Company no longer has any
A shares in issue.
16. RESERVES
The following describes the nature
and purpose of each reserve within shareholders' equity:
Accumulated
losses
Cumulative losses recognised in the
Consolidated Statement of Comprehensive Income.
Share based payment
reserve
The share based payment reserve is
the cumulative amount recognised in relation to the equity-settled
share based payment scheme as further described in Note
18.
17. FINANCIAL INSTRUMENTS AND ASSOCIATED
RISKS
The fair value measurement of the
Group's financial and non-financial assets and liabilities
utilities market observable inputs and data as far as possible.
Inputs used in determining fair value measurements are categorised
into different levels based on how observable the inputs used in
the valuation technique utilised are (the "fair value hierarchy"):
Level 1: Quoted prices in active
markets for identical items;
Level 2: Observable direct or
indirect inputs other than Level 1 inputs; and
Level 3: Unobservable inputs, thus
not derived from market data.
The classification of an item into
the above levels is based on the lowest level of the inputs used
that has a significant effect on the fair value measurement of the
item. Transfers of items between levels are recognised in the year
they occur.
The Group has the following
categories of financial instruments as at 30 June 2024:
|
As at
30 June
2024
|
|
As at
30 June
2023
|
|
£'s
|
|
£'s
|
Financial assets measured at amortised cost
|
|
|
|
Cash and cash equivalents (Note
12)
|
6,461,475
|
|
7,783,448
|
Due from related party (Note
19)
|
1
|
|
1
|
|
6,461,476
|
|
7,783,449
|
|
|
|
|
Financial liabilities measured at amortised
cost
|
|
|
|
Trade payables (Note 13)
|
376,645
|
|
165,661
|
Due to related party (Note
19)
|
635,213
|
|
179,192
|
Accruals (Note 13)
|
1,866,209
|
|
158,602
|
Other creditors
|
623,068
|
|
-
|
A1 ordinary share liability (Note
18)
|
65,400
|
|
65,400
|
|
3,566,535
|
|
568,855
|
Financial liabilities measured at measure at fair value to
profit and loss
|
|
|
|
Warrant Liability (Note
14)
|
2,088,000
|
|
2,667,000
|
|
2,088,000
|
|
2,667,000
|
All financial instruments are
classified as current assets and current liabilities. There are no
non-current financial instruments as at 30 June 2024.
For details of the fair value
hierarchy, valuation techniques, and significant unobservable
inputs related to determining the fair value of the warrant
liability, which is classified in level 3 of the fair value
hierarchy, refer to Note 14.
The Group's risk management policies
are established to identify and analyse the risks faced by the
Group, to set appropriate risk limits and controls, and to monitor
risks and adherence limits. Risk management policies and systems
are reviewed regularly to reflect changes in market conditions and
the Group's activities. Treasury activities are managed on a Group
basis under policies and procedures approved and monitored by the
Board.
Treasury activities are managed on a
Group basis under policies and procedures approved and monitored by
the Board. These are focussed on maximising the interest earned by
the Group on its cash deposits (refer note 12) through effective
management of the amount available to be placed on deposit being
cognisant of the ongoing working capital requirements of the
Group. Any movement in interest rates will not have a
significant effect on the Group or its ability to continue to
pursue its stated strategy and such movements are therefore not
considered to be a material risk to the Group.
As the Group's assets are
predominantly cash and cash equivalents, market risk, and liquidity
risk are not currently considered to be
material risks to the Group. The Directors have reviewed the risk
of holding a singular concentration of assets as predominantly all
credit assets held are cash and cash equivalents, however, do not
deem this a material risk. The risk is mitigated by all cash and
cash equivalents being held with Barclays Bank plc, which holds a
short-term credit rating of P-1 (2023: P-1), as issued by
Moody's.
18. SHARE-BASED PAYMENTS
Management Long Term
Incentive Arrangements
The Group has put in place a
Long-Term Incentive Plan ("LTIP"), to ensure alignment
between Shareholders, and those responsible for delivering the
Company's strategy and attract and retain the best executive
management talent.
The LTIP will only reward the
participants if shareholder value is created. This ensures
alignment of the interests of management directly with those of
Shareholders.
On inception of the LTIP,
"Incentive
Shares" were issued by the Company's
subsidiary to Marwyn Long Term Incentive LP ("MLTI"). On 17 June 2022, the
Incentive Shares in the Company's subsidiary were redesignated into
A1 Ordinary Shares ("A1
Shares") and A2 Ordinary Shares
("A2
Shares") and the Incentive shares
issued to MLTI were redesignated as A2 Shares.
Mark Hodges, Will Self, and James
Pearce were issued A1 Shares on 19 June 2022, 5 June 2023, and 22
May 2024 respectively. James Pearce's shares will only
commence vesting when he is made a permanent employee of the
Group.
Preferred
Return
The incentive arrangements are
subject to the Company's shareholders achieving a preferred return.
Up until 27 June 2024, the preferred return was at least 7.5
percent per annum on a compounded basis on the capital they have
invested from time to time (with dividends and returns of capital
being treated as a reduction in the amount invested at the relevant
time) (the "Preferred Return"). Effective
27 June 2024, the Preferred Return was increased to 10 percent. The
LTIP including the Preferred Return are described in the prospectus
available on the Company's website (www.marwynac2.com/investors).
Incentive
Value
Subject to a number of provisions
detailed below, if the Preferred Return and at least one of the
vesting conditions have been met, the holders of the Incentive
Shares can give notice to redeem their Incentive Shares for
Ordinary Shares in the Company ("Ordinary
Shares") for an aggregate value
equivalent to 20 per cent. of the "Growth", where Growth means the
excess of the total equity value of the Company and other
shareholder returns over and above its aggregate paid up share
capital (20 per cent. of the Growth being the "Incentive
Value").
Grant date
The grant date of the Incentive
Shares will be the date that such shares are issued.
Service Conditions and Leaver Provisions
There are leaver provisions in
relation to the A1 Shares which are set out in the subscription
agreements entered into between the holders of the A1 Shares and
MAC II (BVI) Limited.
If the holder leaves in
circumstances in which he or she is deemed to be a
"Good
Leaver" (being any reason other than
a bad leaver circumstance), then the holder of the A1 Shares will
be entitled to the vested portion of the A1 Shares and in respect
of the remainder of the A1 Shares the holder will be required to
enter into documentation under which, at the election of the
Company or MAC II (BVI) Limited the remainder of the A1 Shares will
be compulsorily redeemed or acquired at the lower of the (i) the
subscription price or (ii) the market value for such A1 Shares or
the A1 Shares may be converted into Ordinary Shares in the Company.
Any holder deemed to be a "Bad
Leaver" (such as termination of
employment for gross misconduct, fraud or criminal acts) will be
required to sell his A1 Shares back to MAC II (BVI) Limited for a
total consideration of £0.01. As there are conditions whereby the
unvested portion of the A1 Shares can be redeemed or acquired at
the lower of the (i) the subscription price or (ii) the market
value for such A1 Shares, the amount received on the issue of A1
Shares is recognised as a liability In the Financial
Statements.
Redemption /
Exercise
Unless otherwise determined and
subject to the redemption conditions having been met, the Company
and the holders of the Incentive Shares have the right to exchange
each Incentive Share for Ordinary Shares, which will be dilutive to
the interests of the holders of Ordinary Shares. However, if the
Company has sufficient cash resources and
the Company so determines, the Incentive Shares may instead be
redeemed for cash. It is currently expected that in the ordinary
course Incentive Shares will be exchanged for Ordinary Shares.
However, the Company retains the right but not the obligation to
redeem the Incentive Shares for cash instead. Circumstances where
the Company may exercise this right include, but are not limited
to, where the Company is not authorised to issue additional
Ordinary Shares or on the winding-up or takeover of the
Company.
Any holder of Incentive Shares who
exercises their Incentive Shares prior to other holders is entitled
to their proportion of the Incentive Value to the date that they
exercise but no more. Their proportion is determined by the number
of Incentive Shares they hold relative to the total number of
issued shares of the same class.
Vesting Conditions and
Vesting Period
The Incentive Shares are subject to
certain vesting conditions, at least one of which must be (and
continue to be) satisfied in order for a holder of Incentive Shares
to exercise its redemption right. The
vesting conditions are as follows:
i.
it is later than the third anniversary of the initial acquisition
and earlier than the seventh anniversary of the
Acquisition;
ii.
a sale of all or substantially all of the revenue or net assets of
the business of the Subsidiary in combination with the distribution
of the net proceeds of that sale to the Company and then to its
shareholders;
iii.
a sale of all of the issued Ordinary Shares of the Subsidiary or a
merger of the Subsidiary in combination with the distribution of
the net proceeds of that sale or merger to the Company's
shareholders;
iv.
where by corporate action or otherwise, the Company effects an
in-specie distribution of all or substantially all of the assets of
the Group to the Company's shareholders;
v.
aggregate cash dividends and cash capital returns to the Company's
Shareholders are greater than or equal to aggregate subscription
proceeds received by the Company;
vi.
a winding-up of the Company;
vii.
a winding-up of the Subsidiary; or
viii. a
sale, merger or change of control of the Company.
If any of the vesting conditions
described in paragraphs (ii) to (viii) above are satisfied before
the third anniversary of the initial acquisition, the Incentive
Shares will be treated as having vested in full.
Holding of Incentive
Shares
MLTI, Mark Hodges, Will Self and
James Pearce (subject to being made a permanent employee) hold
Incentive Shares entitling them in aggregate to 100 per cent. of
the Incentive Value. Any future management partners or senior
executive management team members receiving Incentive Shares will
be dilutive to the interests of existing holders of Incentive
Shares, however the share of the Growth of the Incentive Shares in
aggregate will not increase.
The following shares were in issue
at 30 June 2024:
Issue date
|
Name
|
Share designation at balance sheet
date
|
Nominal Price
|
Issue price per A ordinary
share
£'s
|
Number of A Ordinary
Shares
|
Unrestricted market value at grant
date £'s
|
IFRS 2 Fair value
£'s
|
25 November 2020
|
MLTI
|
A2
|
£0.01
|
7.50
|
2,000
|
15,000
|
169,960
|
19 June 2022
|
Mark Hodges
|
A1
|
£0.01
|
23.50
|
2,000
|
47,000
|
166,275
|
5 June 2023
|
Will Self
|
A1
|
£0.01
|
23.00
|
800
|
18,400
|
60,000
|
22 May 2024
|
James Pearce
|
A1
|
£0.01
|
26.65
|
400
|
10,660
|
36,094
|
Valuation of Incentive
Shares
Valuations were performed by
Deloitte LLP using a Monte Carlo model to ascertain the
unrestricted market value and the fair value at grant date. Details
of the valuation methodology and estimates and judgements used in
determining the fair value are noted herewith and were in
accordance with IFRS 2 at grant date.
There are significant estimates and
assumptions used in the valuation of the Incentive Shares.
Management has considered at the grant date, the probability of a
successful first Business Acquisition by the Company and the
potential range of value for the Incentive Shares, based on the
circumstances on the grant date.
The cumulative unrestricted market
value at grant date is equal to the tax paid value of the shares.
Under the terms of their subscription agreements, the tax value
paid by Mark Hodges and Will Self is payable to them in certain
circumstances; accordingly, the cumulative unrestricted market
value at grant date of their A1 shares, £65,400, is recognised as
an A share liability (2023: £65,400), being the tax paid value of
the shares. The fair value of the Incentive
Shares granted under the scheme was calculated using a Monte Carlo
model with the following inputs:
Issue
date
|
Name
|
Share
designation at balance sheet date
|
Volatility
|
Risk-free
rate
|
Expected
term* (years)
|
25 November 2020
|
MLTI
|
A2
|
25%
|
0.0%
|
7.0
|
19 June 2022
|
Mark Hodges
|
A1
|
30%
|
2.2%
|
7.1
|
5 June 2023
|
Will Self
|
A1
|
30%
|
4.4%
|
7.2
|
22 May 2024
|
James Pearce
|
A1
|
30%
|
4.1%
|
7.5
|
*The expected term assumes that the Incentive Shares are
exercised 7 years post acquisition.
The Incentive Shares are subject to
the Preferred Return being achieved, which is a market performance
condition, and as such has been taken into consideration in
determining their fair value. The model incorporates a range of
probabilities for the likelihood of a Business Acquisition being
made of a given size.
Expense related to Incentive
Shares
An expense of £43,510 (2023:
£30,512) has been
recognised in the Statement of Comprehensive Income in respect of
the Incentive Shares in issue during the year. There is a service
condition associated with the shares issued to both Mark Hodges and
Will Self which requires the fair value charge associated with
these shares to be allocated over the minimum vesting period. These
vesting periods are estimated to be 4.0 years and 3.04 years
respectively from the date of grant.
Under the terms of James Pearce's
subscription letter, the A1 Shares that he has subscribed for will
be transferred to the Company at a price of 1p per share should
James not be made a permanent employee of the Group prior to the
expiration of his fixed term contract. As James is not yet a
permanent employee, no expense has been recognised in year in
relation his shares.
There are no service conditions
attached to the MLTI shares and as result the fair value at grant
date was expensed to the profit and loss account on
issue.
19. RELATED PARTY TRANSACTIONS
James Corsellis has served as a
director of the Company during the year and Antoinette Vanderpuije
is the Company Secretary of the Company. Funds managed by MIM LLP,
of which James Corsellis is the Chief Investment Officer, and
Antoinette Vanderpuije is a partner, held 75 per cent. of the
Company's issued Ordinary Shares and warrants and 100% of the A
shares and A warrants at the year end date as well as the Sponsor
Share. The £1 due for, the Sponsor Share remains unpaid at the year
end (2023: unpaid). As set out in Note 22 of these Financial
Statements, the Company issued 30,000,000 New Ordinary Shares on 4
July 2024, of which 16,688,667 were issued to MIM LLP and as part
of this transaction the 12,000,000 A shares in issue were converted
to Ordinary Shares and the matching A warrants surrendered and
cancelled. As a result, as at the date of this report MIM LLP
manages 68.4% of the Company's Ordinary Shares and 1 sponsor share,
with the ordinary shareholding expected to fall to 59.8% upon issue
of the Consideration Shares. As at 30 June 2024, funds managed by
MIM LLP had paid the Company £73,068 (2023: £Nil) in respect of the
placing of the additional 30,000,000 shares. These shares were
subject to admission no later than 4 July 2024, and before this
point their issue was revocable by the Company. As such the £73,068
is recorded on the Company's Balance Sheet within Other
Creditors.
As at 30 June 2024 Will Self had
paid the Company £50,000 (2023: £Nil) in respect of shares. These
shares were subject to admission no later than 4 July 2024, and
before this point their issue was revocable by the Company: as such
the £50,000 is recorded on the Company's Balance Sheet within Other
Creditors.
James Corsellis and Antoinette
Vanderpuije have an indirect beneficial interest in the A2 Ordinary
Shares issued by MAC II (BVI) Limited to Marwyn Long Term Incentive
LP which is disclosed in Note 18.
Mark Hodges, Will Self, and James
Pearce have a direct interest in the A1 Ordinary Shares issued by
MAC II (BVI) Limited, as disclosed in Note 18.
James Corsellis is also the managing
partner of Marwyn Capital LLP ("MCLLP"), and Antoinette Vanderpuije is
a partner, which provides corporate finance support, company
secretarial, administration and accounting services to the Company.
On an ongoing basis a monthly fee of £52,350 per calendar month
(£50,000 up to December 2023) is charged for the provision of the
corporate finance services, and managed services support is charged
on a time spent basis. The total amount of charges incurred,
inclusive of VAT, in the year ended 30 June 2024 by MCLLP for
services was £1,321,395 (2023: £762,795); they had incurred
expenses on behalf of the Company of £65,497 (2023: £92,425); and
the aggregate amount due to MCLLP at year end was £635,213 (2023:
£179,192). The total amount of charges incurred in the year ended
30 June 2024 included one-off corporate finance service fees of
£360,000 (2023: £Nil), and one-off managed service fees of £180,747
(2023: £Nil) in respect of Acquisition related fees.
On the 21 June 2024 the Company
entered into a new corporate services and advisory agreement with
MCLLP, which includes the provision of strategic company
secretarial services, including LSE/FCA compliance (with Antoinette
Vanderpuije serving as the named company secretary) for an annual
fee of £150,000. MCLLP's additional roles include M&A, research
and due diligence support, as well as equity capital markets
support, M&A execution and project management of workstreams.
Fees for these services will be agreed on a project-by-project
basis prior to the start of the specific workstream. Until such
time that the Company becomes self sufficient, MCLLP will provide
company secretarial and corporate governance, reporting, human
resources and other administrative support billed on a time cost
basis. MCLLP also provides the Company's current office and
infrastructure with no fee for the first 12 months, after which the
fee will be reviewed semi-annually or such time as the parties
agree. The new agreement was effective on admission, which was the
4 July 2024.
The Company has been recharged costs
associated with provision of project services of £Nil (2023:
£10,750 due to the Company) inclusive of VAT from Marwyn
Acquisition Company III Limited ("MAC III"), of which £Nil (2023: £Nil)
was due to the Company at year end. MAC III is related to the Group
through James Corsellis being the chairman of MAC III during the
year.
Directors' emoluments, in relation
to Mark Hodges, Will Self, Cathryn Riley, and James Pearce, are
disclosed in Note 5 with details of Incentive Shares issued are
outlined in Note 18.
Subsequent to the year end, the
Company has entered a service agreement with James Corsellis under
which he will receive an annual fee of £75,000.
20. COMMITMENTS AND CONTINGENT
LIABILITIES
There were no commitments or
contingent liabilities outstanding at 30 June 2024 (2023: £Nil)
that require disclosure or adjustment in these Financial
Statements.
21. INDEPENDENT AUDITOR'S REMUNERATION
Audit fees payable for the year
ended 30 June 2024 are £24,580
(2023: £23,000). Fees payable for the year ended
30 June 2024 in respect of any non-audit related procedures
are £Nil (2023:
£Nil).
22. POST BALANCE SHEET EVENTS
On 27 June 2024, the Company's
wholly owned subsidiary, MAC II UK Limited, agreed to acquire 100
per cent. of the issued share capital of InvestAcc a leading
pensions service provider for £41.5 million representing an
enterprise value of approximately £36 million on an Acquisition
basis. InvestAcc is a company incorporated, managed and controlled
in the UK. The Acquisition is subject to FCA approval, which has
not yet been received, and therefore at the date of signing these
financial statements the Company had not completed the Acquisition.
It is anticipated that completion will take place in Q3 or Q4 of
this calendar year.
The Company has financed the
Acquisition through a placing of Ordinary Shares and existing cash
resources. On 4 July 2024, the Company announced the successful
placing of and subscription for 30,000,000 New Ordinary Shares, at
a price of £1 per share. On this date the Company also announced
that the 12,000,000 unlisted A Shares then in issue has been
converted into Ordinary Shares and the 12,000,000 A Warrants then
in issue has been surrendered and cancelled. As at the date of
signing these Financial Statements, the Company has in issue
42,700,000 Ordinary Shares of no par value.
As part of the placing, Will Self
subscribed for 50,000 Ordinary Shares and Mark Hodges subscribed
for 150,000 Ordinary Shares.
Conditional upon the completion of
the Acquisition, a further 6,150,911 consideration shares will be
admitted to trading on the standard segment of the Official List
and to Transition Category of the London Stock Exchange.
No other matter or circumstance has
arisen since 30 June 2024 that has significantly affected, or may
significantly affect the consolidated entity's operations, the
results of those operations, or the consolidated entity's state of
affairs in future financial years.
ADVISERS
Company Secretary
|
Company Broker
|
Antoinette Vanderpuije
|
Zeus Capital Limited
|
11 Buckingham Street
|
125 Old Broad Street
|
London
|
London
|
WC2N 6DF
|
EC2N 1AR
|
Email: MAC2@marwyn.com
|
|
|
|
English legal advisers to the Company
|
Registered Agent
|
Travers Smith LLP
|
Conyers Trust Company (BVI)
Limited
|
10 Snow Hill
|
Commerce House
|
London
|
Wickhams Cay 1
|
EC1A 2AL
|
Road Town
|
|
VG1110
|
|
Tortola
|
|
British Virgin Islands
|
|
|
Depository
|
BVI
legal advisers to the Company
|
Link Market Services Trustees
Limited
|
Conyers Dill &
Pearman
|
The Registry
|
Commerce House
|
34 Beckenham Road
|
Wickhams Cay 1
|
Beckenham
|
Road Town
|
Kent
|
Tortola
|
BR3 4TU
|
British Virgin Islands
|
|
VG1110
|
|
|
Independent auditor
|
Registrar
|
Baker Tilly Channel Islands
Limited
|
Link Market
Services (Guernsey) Limited
|
2nd Floor, Lime Grove
House
|
Mont Crevelt House
|
Green Street
|
Bulwer Avenue
|
St Helier
|
St Sampson
|
Jersey
|
Guernsey
|
JE2 4UB
|
GY2 4LH
|
|
|
Assistant Company Secretary
|
|
Conyers Corporate Services (BVI)
Limited
|
|
Commerce House
|
|
Wickhams Cay 1
|
|
Road Town
|
|
VG1110
|
|
Tortola
|
|
British Virgin Islands
|
|